Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Tropicalsunon Apr 08, 2021 5:02pm
133 Views
Post# 32959568

RE:RE:RE:RE:RE:RE:UofA study results out

RE:RE:RE:RE:RE:RE:UofA study results outOats, and Ciao,

 both of you and a few others on this board that have been in the Ceapro story for quite sometime, know all to well that Gille's is all about the science, and very little on the promotional side of things. Todays news release is very significant in that there is now the data to back up the claim, I agree with the comment made that most retail investors won't get it, atleast until they understand what today's news could translate into for the company down the road.

We can only hope that the long drought of news has come to an end, and that today starts the cycle of material change for this company. I believe that with the science, so to will come the time to really get the story out to the institutional community, the retail side will follow. Of course that part will fall on Jenene Thomas and her team, I am not sure if we are there yet, as we have all been dissapointed too many times in the past. Hope really is a piss poor plan, but sometimes that's all we got. GLTA
<< Previous
Bullboard Posts
Next >>